Skip to main content
. 2012 Sep 15;23(18):3677–3693. doi: 10.1091/mbc.E12-01-0046

TABLE 2A:

Consensus patterns, secondary structure element, relative surface accessibility, and direct CRM1-binding results for experimental NESs with available 3D structures. Continued

Protein name NESdb ID UniProt ID NES sequencea Consensus fitb PDB ID SSEc RSA-NESd RSA-Φse Bind CRM1f
Snurportin 1 O95149 1MEELSQALASSFSV14 + 3GB8 HHHHHHHHHHCCCC 0.57 0.74 +
HIV-REV 2 P69718 72PLQLPPLERLTL83 + 3NBZ CCCCCCHHHCCC 0.77 0.81 NT
PKIα 5 P61925 36NELALKLAGLDI47 + 3NBY HHHHHHHCCCCC 0.58 0.71 +
p53 6 P04637 336ERFEMFRELNEALEL350 + 1OLG HHHHHHHHHHHHHHH 0.31 0.12 NT
RanBP1 7 P43487 175DHAEKVAEKLEALSV189 + 1K5D --------------- 1.00 1.00 +
BRCA1 10 P38398 81QLVEELLKIICAFQL95 + 1JM7 HHHHHHHHHHHHHHH 0.41 0.34 NT
MAPKK1/MEK1 11 Q05116 28TNLEALQKKLEELEL42 + 2Y4I ---------CCCCCC 0.88 0.76 +
MK2 20 P49138 337DVKEEMTSALATMRV351 + 1KWP HHHHHHHHHHHHHCC 0.29 0.12 +
Stat1 27 P42224 395STNGSLAAEFRHLQL409 + 1BF5 CCCCCEEEEEEEEE 0.24 0.01 +
mPER2 31 O54943 455PSVQELTEQIHRLLM469 + 3GDI HHHHHHHHHHHHHCC 0.40 0.20 +
PLC-δ1 33 P10688 160MNFKELKDFLKELNI174 + 1DJX EEHHHHHHHHHCCCC 0.39 0.20 +
p73 39 O15350 363ENFEILMKLKESLEL377 + 2WTT HHHHHCCHHHHHHHC 0.09 0.09 +
Smad1 40 Q15797 400FETVYELTKMCTIRM414 + 1KHU HHHHHHHHHHHEEEE 0.29 0.05 NT
λPKC 42 Q62074 241SGKASSSLGLQDFDL255 + 1ZRZ -------CCCCCEEE 0.63 0.25 NT
Yap1p   45 P19880 609PKYSDIDVDGLCSEL623 - 1SSE CCCCCCCHHHHHHHH 0.46 0.23 +
Cyclin D1 54 P24385 281VDLACTPTDVRDVDI295 + 3G33 --------------- 1.00 1.00 NT
p38 56 P0C796 119YGEKTTQRDLTELEI133 + 1N93 CCCCCCCCCCCHHHH 0.50 0.38 NT
E2F4 65 Q16254 56RRIYDITNVLEGIGL70 + 1CF7 HHHHHHHHHHHHHCC 0.37 0.41 +
RSV M 79 P03419 192AKIIPYSGLLLVITV206 2VQP CEEECCCCCEEEEEC 0.11 0.03 NT
FAK1 83 Q05397 90LRSEEVHWLHVDMGV104 + 2AEH CCCCCEEEECCCCEH 0.32 0.18 NT
Q00944 90LQSEEVHWLHLDMGV104
FAK1 83 Q05397 511LQVRKYSLDLASLIL525 + 1MP8 HHHCCCCCCHHHHHH 0.34 0.14 NT
Vpr 86 P05928 55AGVEAIIRILQQLLF69 + 1ESX CHHHHHHHHHHHHHH 0.43 0.54 NT
Q73369 55TGVEALIRILQQLLF69
nsP2 92 P36328 514IVLNQLCVRFFGLDL528 + 2HWK HHHHHHHHHHHCCCH 0.03 0.04 NT
NPM 93 P06748 88SLGGFEITPPVVLRL102 + 2P1B EEEEEEECCCEEEEE 0.19 0.16 NT
NPM mutA 94 P06748 282EAIQDLCLAVEEVSL296 + 2VXD --------------- 1.00 1.00 +
CHP1 96 Q99653 133DELLQVLRMMVGVNI147 + 2CT9 HHHHHHHHHHCCCCC 0.38 0.49 +
E1A 99 P03255 69SVMLAVQEGIDLLTF83 + 2KJE CCCHHHCCCCCHHHC 0.44 0.49 +
ADAR1 110 P55265 126LSSHFQELSI135 + 1QGP CHHHHCCCHH 0.66 0.71 +
E7 114 P03129 70QSTHVDIRTLEDLLM84 + 2EWL ECCHHHHHHHHHHHH 0.48 0.45 +
P21736 78ESSAEDLRTLQQLFL91
N protein 118 Q88935 103EFSLPTHHTVRLIRV117 + 1P65 CCCCCHHHHHHHHHH 0.52 0.60 NT
Hxk2 120 P04807 304MSSGYYLGEILRLAL318 + 1IG8 HHCHHHHHHHHHHHH 0.06 0.05 NT
Topo IIα 121 P11388 1013DTVLDILRDFFELRL1027 + 1BGW CCHHHHHHHHHHHHH 0.21 0.09 +
P06786 988NSVNEILSEFYYVRL1002
Survivin 123 O15392 84CAFLSVKKQFEELTL98 + 2QFA CHHHHCCCCHHHCCH 0.43 0.33 NT
NC2β 126 Q01658 66ISPEHVIQALESLGF80 + 1JFI CCHHHHHHHHHHHCC 0.34 0.23 +
Tbx5 127 Q9PWE8 146AHWMRQLVSFQKLKL160 + 2X6U HHHHHCCEECCCCEE 0.28 0.10 NT
Paxillin 136 P49023 262ATRELDELMASLSDF276 + 2VZI CHHHHHHHHHHC--- 0.76 0.70 +
BPV E1 139 P03116 404YQNIELITFINALKL418 + 2V9P   HCCCCHHHHHHHHHH 0.29 0.18 NT
CaMKIα 143 Q63450 307FNATAVVRHMRKLQL321 + 1A06 ECHHHHHHHC----- 0.58 0.79 +
STRADα 154 Q7RTN6 412SGIFGLVTNLEELEV426 + 3GNI -------------CC 1.04 0.83 +
LEI 155 P30740 279EESYTLNSDLARLGV293 + 1HLE EEEEECHHHHHHHCC 0.28 0.06 +
P05619 279EESYDLTSHLARLGV293
MK5 165 O54992 328GIQQAHAEQLANMRI342 + 2OZA HHHHHHHHHHHHHCC 0.33 0.20 NT
P49137 351DVKEEMTSALATMRV365
Dab1 168 P97318 146AAEPVILDLRDLFQL160 + 1OQN CCHHHHHHHHHHHHH 0.26 0.08 NT
p28GANK 173 O75832 1MEGCVSNLMV10 + 1QYM --CCCCCHH 0.61 0.41 NT
2EGCVSNLMV10
SIRT2 199 Q8IXJ6 37DMDFLRNLFSQTLSL51 + 1J8F HHHHHHHHC------ 0.61 0.58 +
Hst2 212 P53686 303EQLLEIVHDLENLSL317 + 1Q14 CHHHHHHHHHHC--- 0.46 0.60 NT
PP2ACα 213 P67775 144NVMKYFTDLFDYLPL155 + 2IAE CHHHHHHHHHHHCCC 0.10 0.00 NT
ORF-9b 214 P59636 41KVYPIILRLGSNLSL55 + 2CME EEEEEEECCCCCCEE 0.28 0.19 NT